<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: operations", fill: "#cb6d51"},
{source: "1: operations", target: "1: financial condition", fill: "#cb6d51"},
{source: "1: financial condition", target: "1: various risks", fill: "#cb6d51"},
{source: "1: various risks", target: "1: uncertainties", fill: "#cb6d51"},
{source: "1: operations", target: "6: The Company ", fill: "#f7f"},
{source: "6: The Company ", target: "6: participates", fill: "#f7f"},
{source: "6: participates", target: "6: highly competitive environment", fill: "#f7f"},
{source: "6: The Company ", target: "9: face intense", fill: "#cd5b45"},
{source: "9: face intense", target: "9: competition from", fill: "#cd5b45"},
{source: "9: competition from", target: "9: manufacturers", fill: "#cd5b45"},
{source: "9: face intense", target: "23: materials could impact", fill: "#f0f"},
{source: "23: materials could impact", target: "23: companys ability", fill: "#f0f"},
{source: "23: companys ability", target: "23: manufacture", fill: "#f0f"},
{source: "23: manufacture", target: "23: could increase", fill: "#f0f"},
{source: "23: materials could impact", target: "24: reimbursement", fill: "#98fb98"},
{source: "24: reimbursement", target: "24: negatively", fill: "#98fb98"},
{source: "24: negatively", target: "24: the Companys ", fill: "#98fb98"},
{source: "24: the Companys ", target: "24: profitability", fill: "#98fb98"},
{source: "24: reimbursement", target: "26: products directly from", fill: "#df73ff"},
{source: "26: products directly from", target: "26: programs home respiratory care providers", fill: "#df73ff"},
{source: "26: programs home respiratory care providers", target: "26: durable medical equipment", fill: "#df73ff"},
{source: "26: durable medical equipment", target: "26: primary customers", fill: "#df73ff"},
{source: "26: primary customers", target: "26: Companys ", fill: "#df73ff"},
{source: "26: Companys ", target: "26: products depend heavily on payments from", fill: "#df73ff"},
{source: "26: products depend heavily on payments from", target: "26: Medicare Medicaid ", fill: "#df73ff"},
{source: "26: products directly from", target: "45: manufacturing marketing", fill: "#ff0028"},
{source: "45: manufacturing marketing", target: "45: medical devices", fill: "#ff0028"},
{source: "45: medical devices", target: "45: liability", fill: "#ff0028"},
{source: "45: liability", target: "45: could seriously harm", fill: "#ff0028"},
{source: "45: could seriously harm", target: "45: particularly", fill: "#ff0028"},
{source: "45: particularly", target: "45: insurance coverage", fill: "#ff0028"},
{source: "45: manufacturing marketing", target: "START_HERE", fill: "#ff0028"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Health Care Supplies</td>
    </tr>
    <tr>
      <td>Health Care</td>
    </tr>
    <tr>
      <td>Health Care Equipment and Services</td>
    </tr>
    <tr>
      <td>Managed Health Care</td>
    </tr>
    <tr>
      <td>Construction and Engineering</td>
    </tr>
    <tr>
      <td>Construction Materials</td>
    </tr>
    <tr>
      <td>Construction and Farm Machinery and Heavy Trucks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Policy</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_director">Operations director</a></td>
      <td>The role of operations director generally encompasses the oversight of operational aspects of company strategy with responsibilities to ensure operation information is supplied to the chief executive and the board of directors as well as external parties.\n\n\n== Description ==\nThe role of operations director can vary according to the size of a company, and at some companies many even encompass some or all the functions of a chief operating officer.The Institute of Directors of the United Kingdom defines the role as overseeing "all operational aspects of company strategy" and "responsible for the flow of operations information to the chief executive, the board and, where necessary, external parties such as investors or financial institutions".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_condition_report">Financial condition report</a></td>
      <td>In accounting, a financial condition report (FCR) is a report on the solvency condition of an insurance company that takes into account both the current financial status, as reflected in the balance sheet, and an assessment of the ability of the company to survive future risk scenarios. Risk assessment in an FCR involves dynamic solvency testing, a type of dynamic financial analysis that simulates management response to risk scenarios, to test whether a company could remain solvent in the face of deteriorating economic conditions or major disasters.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Balance_sheet">Balance sheet</a></td>
      <td>In financial accounting, a balance sheet (also known as statement of financial position or statement of financial condition) is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity. Assets, liabilities and ownership equity are listed as of a specific date, such as the end of its financial year.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_statement">Financial statement</a></td>
      <td>Financial statements (or financial reports) are formal records of the financial activities and position of a business, person, or other entity.\nRelevant financial information is presented in a structured manner and in a form which is easy to understand.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_ratio">Financial ratio</a></td>
      <td>A financial ratio or accounting ratio is a relative magnitude of two selected numerical values taken from an enterprise's financial statements. Often used in accounting, there are many standard ratios used to try to evaluate the overall financial condition of a corporation or other organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_law">Financial law</a></td>
      <td>Financial law is the law and regulation of the insurance, derivatives, commercial banking, capital markets and investment management sectors. Understanding Financial law is crucial to appreciating the creation and formation of banking and financial regulation, as well as the legal framework for finance generally.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Trustmark_(bank)">Trustmark (bank)</a></td>
      <td>Trustmark is a commercial bank and financial services company headquartered in Jackson, Mississippi, United States, with subsidiaries Trustmark National Bank, Trustmark Investment Advisors, and Fisher Brown Bottrell Insurance. The bank's initial predecessor, The Jackson Bank, was chartered by the State of Mississippi in 1889.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Form_10-K">Form 10-K</a></td>
      <td>A Form 10-K is an annual report required by the U.S. Securities and Exchange Commission (SEC), that gives a comprehensive summary of a company's financial performance. Although similarly named, the annual report on Form 10-K is distinct from the often glossy "annual report to shareholders," which a company must send to its shareholders when it holds an annual meeting to elect directors (though some companies combine the annual report and the 10-K into one document).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_takeover_of_Fannie_Mae_and_Freddie_Mac">Federal takeover of Fannie Mae and Freddie Mac</a></td>
      <td>In September 2008 the Federal Housing Finance Agency (FHFA) announced that it would take over the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). Both government-sponsored enterprises, which finance home mortgages in the United States by issuing bonds, had become illiquid as the market for those bonds collapsed in the subprime mortgage crisis.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Walt_Disney_Company">The Walt Disney Company</a></td>
      <td>The Walt Disney Company, commonly known as Disney (), is an American multinational mass media and entertainment conglomerate headquartered at the Walt Disney Studios complex in Burbank, California.\nDisney was originally founded on October 16, 1923, by brothers Walt and Roy O. Disney as the Disney Brothers Cartoon Studio; it also operated under the names the Walt Disney Studio and Walt Disney Productions before changing its name to the Walt Disney Company in 1986.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Holding_company">Holding company</a></td>
      <td>A holding company is a company whose primary business is holding a controlling interest in the securities of other companies. A holding company usually does not produce goods or services itself.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/East_India_Company">East India Company</a></td>
      <td>The East India Company (EIC) was an English, and later British, joint-stock company founded in 1600. It was formed to trade in the Indian Ocean region, initially with the East Indies (the Indian subcontinent and Southeast Asia), and later with East Asia.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Pokémon_Company">The Pokémon Company</a></td>
      <td>The Pokémon Company (株式会社ポケモン, Kabushiki gaisha Pokémon) is a Japanese company responsible for brand management, production, publishing, marketing and licensing of the Pokémon franchise, which consists of video game software, a trading card game, anime television series, films, manga, home entertainment products, merchandise, and other ventures. It was established through a joint investment by the three businesses holding the copyright of Pokémon: Nintendo, Game Freak, and Creatures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Weather_Company">The Weather Company</a></td>
      <td>The Weather Company is a weather forecasting and information technology company that owns and operates weather.com and Weather Underground. The Weather Company has been a subsidiary of the Watson &amp; Cloud Platform business unit of IBM since 2016.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Honest_Company">The Honest Company</a></td>
      <td>The Honest Company, Inc. is an American consumer goods company, founded by actress Jessica Alba.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competition">Competition</a></td>
      <td>Competition is a rivalry where two or more parties strive for a common goal which cannot be shared: where one's gain is the other's loss (an example of which is a zero-sum game). Competition can arise between entities such as organisms, individuals, economic and social groups, etc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Automotive_industry">Automotive industry</a></td>
      <td>The automotive industry comprises a wide range of companies and organizations involved in the design, development, manufacturing, marketing, and selling of motor vehicles. It is one of the world's largest industries by revenue (from 16 % such as in France up to 40 % to countries like Slovakia).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Passeig_de_Lluís_Companys,_Barcelona">Passeig de Lluís Companys, Barcelona</a></td>
      <td>Passeig de Lluís Companys (Catalan pronunciation: [pəˈsɛdʒ də ʎuˈis kumˈpaɲs]) is a promenade in the Ciutat Vella and Eixample districts of Barcelona, Catalonia, Spain, and can be seen as an extension of Passeig de Sant Joan. It was named after President Lluís Companys, who was executed in 1940.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Estadi_Olímpic_Lluís_Companys">Estadi Olímpic Lluís Companys</a></td>
      <td>Estadi Olímpic Lluís Companys (Catalan pronunciation: [əsˈtaði uˈlimpiɡ ʎuˈis kumˈpaɲs], formerly known as the Estadi Olímpic de Montjuïc and Estadio de Montjuic) is a stadium in Barcelona, Catalonia, Spain. Originally built in 1927 for the 1929 International Exposition in the city (and Barcelona's bid for the 1936 Summer Olympics, which were awarded to Berlin), it was renovated in 1989 to be the main stadium for the 1992 Summer Olympics and 1992 Summer Paralympics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Companys,_procés_a_Catalunya">Companys, procés a Catalunya</a></td>
      <td>Companys, procés a Catalunya (Spanish: Companys, proceso a Cataluña) is a 1979 Spanish Catalan drama film directed by Josep Maria Forn, based on the last months of the life of the President of Catalonia, Lluís Companys, in which he shows his detention by the Nazis and his subsequent execution by the Spanish Francoists. It competed in the Un Certain Regard section at the 1979 Cannes Film Festival.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/El_Tarròs">El Tarròs</a></td>
      <td>El Tarròs (Spanish: Tarrós) is a small village in Tornabous municipality, in the province of Lleida, in Catalonia, Spain. In 2008 it had 100 inhabitants.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_largest_companies_in_the_United_States_by_revenue">List of largest companies in the United States by revenue</a></td>
      <td>This list comprises the largest companies in the United States by revenue as of 2022, according to the Fortune 500 tally of companies. Retail corporation Walmart has been the largest company in the US by revenue since 2014.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Amazon_(company)">Amazon (company)</a></td>
      <td>Amazon.com, Inc. ( AM-ə-zon) is an American multinational technology company which focuses on e-commerce, cloud computing, digital streaming, and artificial intelligence.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Legal_liability">Legal liability</a></td>
      <td>In law, liable means  "responsible or answerable in law; legally obligated". Legal liability concerns both civil law and criminal law and can arise from various areas of law, such as contracts, torts, taxes, or fines given by government agencies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Liability_insurance">Liability insurance</a></td>
      <td>Liability insurance (also called third-party insurance) is a part of the general insurance system of risk financing to protect the purchaser (the "insured") from the risks of liabilities imposed by lawsuits and similar claims and protects the insured if the purchaser is sued for claims that come within the coverage of the insurance policy.\nOriginally, individual companies that faced a common peril formed a group and created a self-help fund out of which to pay compensation should any member incur loss (in other words, a mutual insurance arrangement).</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>ALLIED HEALTHCARE PRODUCTS INC      Item 1A  Risk Factors       The Company’s business, <font color="blue">operations</font> and <font color="blue">financial condition</font> are subject to     <font color="blue">various risks</font> and <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>You <font color="blue">should carefully</font> consider the risks and     <font color="blue">uncertainties</font> described below, together with all of the other information in     this annual report on Form 10-K and in the company’s other <font color="blue">filings with</font> the     SEC, before making any <font color="blue">investment decision with respect</font> to the company’s     securities</td>
    </tr>
    <tr>
      <td>The risks and <font color="blue">uncertainties</font> described below may not be the only     ones the <font color="blue">company faces</font></td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font>risks and <font color="blue">uncertainties</font> not presently     known by the company or that the <font color="blue">company currently</font> deems <font color="blue">immaterial may also</font>     affect the company’s business</td>
    </tr>
    <tr>
      <td>If any of these known or unknown                                         9       _________________________________________________________________    [61]Table of <font color="blue">Contents       </font>risks or <font color="blue">uncertainties</font> actually occur or develop, the company’s business,     <font color="blue">financial condition</font>, and results of <font color="blue">operations</font> could change</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font><font color="blue">participates</font> in a <font color="blue">highly competitive environment</font></td>
    </tr>
    <tr>
      <td>The medical device industry is <font color="blue">characterized by rapid technological</font> change,     changing customer needs and <font color="blue">frequent new product introductions</font></td>
    </tr>
    <tr>
      <td>Our products     may be rendered <font color="blue">obsolete as</font> a result of <font color="blue">future innovations</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">face intense</font>     <font color="blue">competition from</font> other <font color="blue"><font color="blue">manufacture</font>rs</font></td>
    </tr>
    <tr>
      <td>Some of our <font color="blue">competitors</font> may be larger     than we are and may have greater financial, technical, research, marketing,     sales, <font color="blue">distribution</font> and other <font color="blue">resources than</font> we do</td>
    </tr>
    <tr>
      <td>We believe that price     <font color="blue">competition <font color="blue">will continue</font> among products</font> developed in our markets</td>
    </tr>
    <tr>
      <td>Our     <font color="blue">competitors</font> may develop or <font color="blue">market <font color="blue">technologies</font></font> and products that are more     <font color="blue">effective</font>  or  <font color="blue">commercially</font>  attractive  than any we are developing or     marketing</td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font> may succeed in obtaining <font color="blue">regulatory approval</font> and     introducing or <font color="blue">commercializing products</font> before we do</td>
    </tr>
    <tr>
      <td>Such <font color="blue"><font color="blue">development</font>s</font>     could  have  a  <font color="blue"><font color="blue">significant</font> negative</font> effect on our business, financial     condition  and  results  of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Even if we are able to compete     <font color="blue">successfully</font>, we may not be able to do so in a <font color="blue">profitable manner</font></td>
    </tr>
    <tr>
      <td><font color="blue">Decreased </font><font color="blue">availability</font> or <font color="blue">increased costs</font> of <font color="blue"><font color="blue">raw materials</font> <font color="blue">could increase</font></font>     the company’s costs of producing its products</td>
    </tr>
    <tr>
      <td>The company purchases <font color="blue">raw materials</font>, fabricated components and <font color="blue">services from</font>     a  variety  of suppliers</td>
    </tr>
    <tr>
      <td>Raw <font color="blue">materials such as brass</font> and plastics are     considered <font color="blue">key <font color="blue">raw materials</font></font></td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>believes that its <font color="blue">relationships</font>     with its suppliers are satisfactory and that <font color="blue">alternative sources</font> of supply     are  readily  available</td>
    </tr>
    <tr>
      <td>From  time  to time, however, the prices and     <font color="blue">availability</font> of these <font color="blue"><font color="blue">raw materials</font> fluctuate due</font> to <font color="blue">global market demands</font>,     <font color="blue">which could impair</font> the company’s ability to <font color="blue">procure <font color="blue">necessary</font> materials</font>, or     increase the cost of <font color="blue">such materials</font></td>
    </tr>
    <tr>
      <td><font color="blue">Inflationary </font>and other increases in     costs of these <font color="blue">raw materials</font> have occurred in the past and <font color="blue">may recur from</font>     time  to time</td>
    </tr>
    <tr>
      <td>In addition, freight costs <font color="blue">associated with</font> shipping and     receiving product and sales are <font color="blue">impacted by <font color="blue">fluctuations</font></font> in the cost of oil     and gas</td>
    </tr>
    <tr>
      <td>A reduction in the supply or increase in the cost of those raw     <font color="blue">materials could impact</font> the company’s ability to <font color="blue">manufacture</font> its products and     <font color="blue">could increase</font> the cost of production</td>
    </tr>
    <tr>
      <td>Changes in third party <font color="blue">reimbursement</font> could <font color="blue">negatively</font> impact the Company’s     revenues and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>The cost of a majority of <font color="blue">medical care</font> in the <font color="blue">United States </font>is <font color="blue">funded by</font> the     <font color="blue">US Government </font>through the <font color="blue">Medicare and Medicaid </font>programs and by private     insurance programs, such as corporate health insurance plans</td>
    </tr>
    <tr>
      <td>Although the     Company does not receive payments for its <font color="blue">products directly from</font> these     programs, home respiratory care providers and <font color="blue">durable medical equipment</font>     suppliers,  who are the <font color="blue">primary customers</font> for several of the Company’s     products, depend heavily on payments from Medicare, Medicaid and private     insurers as a major source of revenues</td>
    </tr>
    <tr>
      <td>In addition, sales of certain of the     Company’s products are <font color="blue">affected by</font> the extent of hospital and <font color="blue">health care</font>     <font color="blue">facility</font>  <font color="blue">construction</font>  and  <font color="blue">renovation at</font> any given time</td>
    </tr>
    <tr>
      <td>The federal     <font color="blue">government indirectly funds</font> a <font color="blue"><font color="blue">significant</font> percentage</font> of such <font color="blue">construction</font>     and <font color="blue">renovation costs through</font> <font color="blue">Medicare and Medicaid </font><font color="blue">reimbursement</font>s</td>
    </tr>
    <tr>
      <td>In recent     years, <font color="blue">governmental</font>ly imposed limits on <font color="blue">reimbursement</font> to hospitals and other     <font color="blue">health care</font> providers have <font color="blue">impacted spending</font> for services, consumables and     capital goods</td>
    </tr>
    <tr>
      <td>A material decrease from current <font color="blue">reimbursement</font> levels or a     material change in the method or basis of reimbursing <font color="blue">health care</font> providers     is likely to <font color="blue"><font color="blue">adversely affect</font> future sales</font> of the Company’s products</td>
    </tr>
    <tr>
      <td>Our  success  <font color="blue">depends upon</font> the <font color="blue">development</font> of <font color="blue">new products</font> and product     <font color="blue">enhancements</font>, which entails considerable time and expense</td>
    </tr>
    <tr>
      <td>We place a <font color="blue">high priority on</font> the <font color="blue">development</font> of <font color="blue">new products</font> to add to our     <font color="blue">product portfolio</font> and on the <font color="blue">development</font> of <font color="blue">enhancements</font> to our existing     products</td>
    </tr>
    <tr>
      <td>Product <font color="blue">development</font> involves substantial expense and we cannot be     certain that a completed <font color="blue">product will generate sufficient revenue</font> for our     business to justify the resources that we devote to research and <font color="blue">development</font>     related  to <font color="blue">such product</font></td>
    </tr>
    <tr>
      <td>The time and expense required to develop new     products and product <font color="blue">enhancements</font> is <font color="blue">difficult</font> to predict and we cannot     assure you that we will succeed in developing, introducing and <font color="blue">marketing new</font>     products and product <font color="blue">enhancements</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to <font color="blue">successfully</font> develop and     introduce  new or <font color="blue">enhanced products on</font> a <font color="blue">timely basis</font> or at all, or to     achieve <font color="blue">market acceptance</font> of <font color="blue">such product</font>s, could materially impair our     business</td>
    </tr>
    <tr>
      <td>10       _________________________________________________________________    [62]Table of <font color="blue">Contents       </font>We  are <font color="blue">dependent on adequate protection</font> of our patent and <font color="blue">proprietary</font>     rights</td>
    </tr>
    <tr>
      <td>We rely on patents, trade secrets, trademarks, copyrights, know-how, license     <font color="blue">agreements</font>  and  <font color="blue">contractual</font>  provisions  to establish and protect our     <font color="blue">intellectual property rights</font></td>
    </tr>
    <tr>
      <td>However, these legal means <font color="blue">afford us only</font>     limited protection and may not <font color="blue">adequately protect</font> our rights or remedies to     gain or keep any <font color="blue">advantages</font> we may have over our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you that <font color="blue">others may</font> not <font color="blue">independently</font> develop the same or     similar <font color="blue">technologies</font> or otherwise obtain access to our <font color="blue">technology</font> and trade     secrets</td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font>, many of which have substantial resources and may     make substantial <font color="blue">investments</font> in competing <font color="blue">technologies</font>, may apply for and     obtain patents that will prevent, limit, or <font color="blue">interfere with</font> our ability to     <font color="blue">manufacture</font> or market our products</td>
    </tr>
    <tr>
      <td>Further, while we do not believe that     any of our products or processes <font color="blue">interfere with</font> the rights of others, third     <font color="blue">parties may nonetheless</font> assert <font color="blue">patent <font color="blue">infringement</font></font> claims <font color="blue">against us</font> in the     future</td>
    </tr>
    <tr>
      <td>Costly <font color="blue"><font color="blue">litigation</font> may</font> be <font color="blue">necessary</font> to <font color="blue">enforce patents issued</font> to us, to     <font color="blue">protect trade secrets</font> or “know-how” we own, to <font color="blue">defend us against</font> claimed     <font color="blue">infringement</font> of the rights of others or to determine the ownership, scope,     or validity of our <font color="blue">proprietary</font> rights and the rights of others</td>
    </tr>
    <tr>
      <td>Any claim of <font color="blue">infringement</font> <font color="blue">against us</font> may involve <font color="blue">significant</font> <font color="blue">liabilities</font> to     third parties, could require us to <font color="blue">seek licenses from third parties</font>, and     could prevent us from <font color="blue">manufacturing</font>, selling, or using our products</td>
    </tr>
    <tr>
      <td>The     occurrence of this <font color="blue">litigation</font> or the effect of an adverse determination in     any of this type of <font color="blue">litigation</font> could have a material adverse effect on our     business, <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our business of the <font color="blue">manufacturing</font>, marketing, and sale of <font color="blue">medical devices</font>     involves the risk of <font color="blue">liability</font> claims and such claims <font color="blue">could seriously harm</font>     our business, <font color="blue">particularly</font> if our <font color="blue">insurance coverage</font> is inadequate</td>
    </tr>
    <tr>
      <td>Our business <font color="blue">exposes us</font> to potential product <font color="blue">liability</font> claims that are     inherent in the testing, production, marketing and sale of <font color="blue">medical devices</font></td>
    </tr>
    <tr>
      <td>Like other <font color="blue">participants</font> in the medical device market, we are from time to     time involved in lawsuits, claims and <font color="blue">proceedings</font> alleging product <font color="blue">liability</font>     and related claims <font color="blue">such as negligence</font></td>
    </tr>
    <tr>
      <td>If any current or future product     <font color="blue">liability</font>  claims  become substantial, our reputation could be damaged     <font color="blue"><font color="blue">significant</font>ly</font>, thereby harming our business</td>
    </tr>
    <tr>
      <td>We may be required to pay     substantial <font color="blue">damage awards as</font> a result of any successful product <font color="blue">liability</font>     claims</td>
    </tr>
    <tr>
      <td>Any product <font color="blue">liability</font> claim <font color="blue">against us</font>, whether with or without     merit, could result in costly <font color="blue">litigation</font>, and divert the time, attention,     and resources of our <font color="blue">management</font></td>
    </tr>
    <tr>
      <td>As a result of our exposure to product <font color="blue">liability</font> claims, we currently carry     product <font color="blue">liability</font> insurance covering our products with policy limits per     occurrence and in the aggregate that we have deemed to be sufficient</td>
    </tr>
    <tr>
      <td>Our     <font color="blue">insurance may</font> not cover certain product <font color="blue">liability</font> claims or our <font color="blue">liability</font>     for any claims may exceed our <font color="blue">coverage limits</font></td>
    </tr>
    <tr>
      <td>Therefore, we <font color="blue">cannot predict</font>     whether this insurance is sufficient, or if not, whether we will be able to     obtain <font color="blue">sufficient insurance</font> to cover the <font color="blue">risks <font color="blue">associated with</font></font> our business     or  whether  such  insurance  will  be  <font color="blue">available at premiums</font> that are     <font color="blue">commercially</font> reasonable</td>
    </tr>
    <tr>
      <td>In addition, these <font color="blue">insurance policies must</font> be     <font color="blue">renewed annually</font></td>
    </tr>
    <tr>
      <td>Although we have been able to obtain <font color="blue">liability</font> insurance,     such <font color="blue">insurance may</font> not be available in the future on acceptable terms, if at     all</td>
    </tr>
    <tr>
      <td>A successful claim <font color="blue">against us</font> or <font color="blue">settlement by us with respect</font> to     uninsured  <font color="blue">liabilities</font>  or in excess of our <font color="blue">insurance coverage</font>, or our     <font color="blue">inability</font> to maintain insurance in the future, or any claim that results in     <font color="blue"><font color="blue">significant</font> costs</font> to or adverse publicity <font color="blue">against us</font>, could have a material     adverse  effect  on  our  business, <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>is subject to substantial domestic and <font color="blue">international government</font>     regulation,  including  <font color="blue">regulatory quality standards applicable</font> to its     <font color="blue">manufacturing</font> and <font color="blue">quality processes</font></td>
    </tr>
    <tr>
      <td>Failure by the Company to <font color="blue">comply with</font>     these standards could have an adverse effect on the Company’s business,     <font color="blue">financial condition</font> or results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>The FDA regulates the approval, <font color="blue">manufacturing</font>, and sales and marketing of     many of the Company’s products in the <font color="blue">US Significant </font><font color="blue">government regulation</font>     also exists in Canada, Japan, Europe, and other countries in which the     Company conducts business</td>
    </tr>
    <tr>
      <td>As a device <font color="blue">manufacture</font>r, the Company is required     to <font color="blue">register with</font> the FDA and is subject to periodic inspection by <font color="blue">the FDA     </font>for <font color="blue">compliance with</font> the FDA’s Quality System Regulation (“QSR”)                                         11       _________________________________________________________________    [63]Table of <font color="blue">Contents       </font><font color="blue">requirements</font>, which require <font color="blue"><font color="blue">manufacture</font>rs</font> of <font color="blue">medical devices</font> to adhere to     <font color="blue">certain <font color="blue">regulations</font></font>, including testing, quality control and <font color="blue">documentation</font>     procedures</td>
    </tr>
    <tr>
      <td>In addition, the federal <font color="blue">Medical Device Reporting </font><font color="blue">regulations</font>     require the Company to provide information <font color="blue">to the FDA </font><font color="blue">whenever there</font> is     evidence  that  <font color="blue">reasonably</font>  suggests  that a device may have caused or     contributed to a death or <font color="blue">serious injury</font> or, if a <font color="blue">malfunction</font> were to occur,     could cause or contribute to a death or <font color="blue">serious injury</font></td>
    </tr>
    <tr>
      <td><font color="blue">Compliance </font>with     <font color="blue">applicable regulatory <font color="blue">requirements</font></font> is subject to <font color="blue">continual review</font> and is     <font color="blue">rigorously</font>  monitored  <font color="blue">through periodic inspections by</font> the FDA In the     European  Community,  the  Company is required to maintain certain ISO     <font color="blue">certifications</font> in order to sell its products and <font color="blue">must undergo periodic</font>     <font color="blue">inspections by notified bodies</font> to obtain and maintain these <font color="blue">certifications</font></td>
    </tr>
    <tr>
      <td><font color="blue">Failure  </font>to  comply  with current <font color="blue">governmental</font> <font color="blue">regulations</font> and quality     assurance  <font color="blue">guidelines</font> could lead to temporary <font color="blue">manufacturing</font> shutdowns,     <font color="blue">product recalls</font> or related field actions, product shortages or delays in     product <font color="blue">manufacturing</font></td>
    </tr>
    <tr>
      <td><font color="blue">Efficacy </font>or safety concerns, an increase in trends of     adverse events in the marketplace, and/or <font color="blue">manufacturing</font> quality issues with     respect to the Company’s <font color="blue">products could lead</font> to <font color="blue">product recalls</font> or related     field actions, withdrawals, and/or declining sales</td>
    </tr>
    <tr>
      <td>Our <font color="blue">products may</font> be subject to <font color="blue">product recalls</font> even after receiving FDA     clearance or approval, which would harm our reputation and our business</td>
    </tr>
    <tr>
      <td>The FDA and similar <font color="blue">governmental</font> <font color="blue">authorities</font> in other countries in which our     products are sold, have the authority to request and, in some cases, require     the recall of our products in the event of material <font color="blue">deficiencies</font> or defects     in design or <font color="blue">manufacture</font></td>
    </tr>
    <tr>
      <td>A government-mandated or <font color="blue">voluntary recall by us</font>     could occur as a result of component failures, <font color="blue">manufacturing</font> errors or     <font color="blue">design defects</font></td>
    </tr>
    <tr>
      <td>Any recall of <font color="blue">product would divert managerial</font> and financial     resources, harm our <font color="blue">reputation with</font> our customers and damage our business</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>is exposed to certain credit risks, resulting <font color="blue">primarily from</font>     <font color="blue">customer sales</font></td>
    </tr>
    <tr>
      <td><font color="blue">Substantially  </font>all  of the Company’s <font color="blue">receivables</font> are <font color="blue">due from homecare</font>     providers, distributors, hospitals, and <font color="blue">contractors</font></td>
    </tr>
    <tr>
      <td>The Company’s customers     are <font color="blue">located throughout</font> the US and around the world</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>records an     estimated  allowance  for <font color="blue">uncollectible amounts based primarily on</font> the     Company’s <font color="blue">evaluation</font> of the payment pattern, <font color="blue">financial condition</font>, cash     flows, and credit history of its <font color="blue">customers as well as current industry</font> and     economic  <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>The Company’s <font color="blue">inability</font> to <font color="blue">collect on</font> its trade     <font color="blue">accounts receivable could substantially reduce</font> the Company’s income and have     a  material  adverse  effect on its <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our <font color="blue"><font color="blue">common stock</font> may fluctuate widely</font></td>
    </tr>
    <tr>
      <td>The  market  price of our <font color="blue"><font color="blue">common stock</font> could</font> be subject to <font color="blue">significant</font>     <font color="blue">fluctuations</font> in response to quarter-to-quarter variation in our operating     results, <font color="blue">announcements</font> of <font color="blue">new products</font> or <font color="blue">services by us</font> or our <font color="blue">competitors</font>,     and other events or factors</td>
    </tr>
    <tr>
      <td>For example, a shortfall in net sales or net     income, or an increase in <font color="blue">losses could</font> have an immediate and <font color="blue">significant</font>     adverse  effect  on the <font color="blue">market price</font> and volume <font color="blue">fluctuations</font> that have     <font color="blue">particularly</font>  affected  the  market  prices  of  many  micro and small     <font color="blue">capitalization</font>  companies  and  that  have  often  been  unrelated  or     <font color="blue">disproportionate</font> to the operating performance of these companies</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">fluctuations</font>,  as  <font color="blue">well as general economic</font> and market <font color="blue">conditions</font>, may     <font color="blue">adversely affect</font> the <font color="blue">market price</font> for our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If a natural or man-made disaster strikes our <font color="blue">manufacturing</font> <font color="blue">facilities</font>, we     may be unable to <font color="blue">manufacture</font> certain products for a substantial amount of     time and our <font color="blue">revenue could decline</font></td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>has one principal <font color="blue">manufacturing</font> operation</td>
    </tr>
    <tr>
      <td>In the event that     this <font color="blue">facility</font>, located in St</td>
    </tr>
    <tr>
      <td>Louis, Missouri, were <font color="blue">severely damaged</font> or     <font color="blue">destroyed as</font> a result of a natural or man-made disaster, the Company would     be  forced  to  <font color="blue">relocate production</font> to other <font color="blue">facilities</font> and/or rely on     third-party <font color="blue"><font color="blue">manufacture</font>rs</font></td>
    </tr>
    <tr>
      <td>Such an event could have a material adverse     effect  on the Company’s business, results of <font color="blue">operations</font> and financial     condition</td>
    </tr>
    <tr>
      <td>Although we have insurance for damage to our property and the     <font color="blue">interruption</font> of our business, this <font color="blue">insurance may</font> not be sufficient in scope     or amount to cover all of our <font color="blue">potential losses</font> and may not continue to be     available to us on acceptable terms, or at all</td>
    </tr>
    <tr>
      <td>12       _________________________________________________________________    [64]Table of <font color="blue">Contents       </font>Requirements <font color="blue">associated with</font> the <font color="blue">evaluation</font> of <font color="blue">internal controls</font> required by     Section 404 of the Sarbanes-Oxley Act of 2002 have required and will require     <font color="blue">significant</font> company resources and <font color="blue">management</font> attention</td>
    </tr>
    <tr>
      <td>Although we believe that we are currently in <font color="blue">compliance with</font> Section 404 of     the Sarbanes-Oxley Act, we may in the future identify material <font color="blue">deficiencies</font>     that we may not be able to <font color="blue">remediate on</font> a <font color="blue">timely basis</font></td>
    </tr>
    <tr>
      <td>If we are not able     to <font color="blue">comply with</font> the <font color="blue">requirements</font> of Section 404 in a <font color="blue">timely manner</font>, we could     be subject to scrutiny by regulatory <font color="blue">authorities</font>, such as the SEC or the     NASDAQ National Market, and the <font color="blue">trading price</font> of our <font color="blue">stock could decline</font></td>
    </tr>
    <tr>
      <td>Moreover,  <font color="blue">effective</font> <font color="blue">internal controls</font> are <font color="blue">necessary</font> for us to produce     reliable  financial reports and are important in helping us to prevent     <font color="blue">financial fraud</font></td>
    </tr>
    <tr>
      <td>If we <font color="blue">cannot provide reliable financial</font> reports or prevent     fraud, our business and operating results could be harmed, investors could     <font color="blue">lose confidence</font> in our reported financial information, and the <font color="blue">trading price</font>     of our stock could drop <font color="blue"><font color="blue">significant</font>ly</font></td>
    </tr>
    <tr>
      <td>If we are unable to hire or retain <font color="blue">key employees</font>, it could have a negative     <font color="blue">impact on</font> our business</td>
    </tr>
    <tr>
      <td>Our  failure  to attract and retain <font color="blue">skilled personnel could hinder</font> the     <font color="blue">management</font> of our business, our research and <font color="blue">development</font>, our sales and     <font color="blue">marketing efforts</font>, and our <font color="blue">manufacturing</font> capabilities</td>
    </tr>
    <tr>
      <td>However, there is no     assurance that we <font color="blue">will continue</font> to be able to hire or retain <font color="blue">key employees</font></td>
    </tr>
    <tr>
      <td>We compete to <font color="blue">hire new employees</font>, and <font color="blue">then must train them</font> and develop their     skills and <font color="blue">competencies</font></td>
    </tr>
    <tr>
      <td>Our operating results could be <font color="blue">adversely affect</font>ed     by  <font color="blue">increased costs</font> due to <font color="blue">increased competition</font> for employees, higher     employee  turnover  or <font color="blue">increased employee benefit costs</font></td>
    </tr>
    <tr>
      <td>Any unplanned     turnover  <font color="blue">could deplete</font> our <font color="blue">institutional knowledge base</font> and erode our     <font color="blue">competitive advantage</font></td>
    </tr>
  </tbody>
</table>